On June 16, 2021, Taiwan FDA1 approved the use of 2’ferrous fumarate syrup-fucosyllactose (2’-FL), produced by genetically&ferrous fnbsp;modified Escherichia coli strain K-12 DH1 MDO MAP1001d, as aferrous gluconate tablets uses novel food ingredient in infant formula, follow-up infant formula,&nbsferrous sulfate folic acid 1 tabletp;and mferrous fumarate + folic acid-tablet 152 mg+1500mcg-livogenilk powder or similar products for children under 7 years old.
Taiwan Permits the Use of 2′-Fucosyllactose in Infant Formula and Children’s Milk Powder
